Flint M, Mullen S, Deatly AM, Chen W, Miller LZ, Ralston R, Broom C, Emini EA, Howe AY. . Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and. Antimicrob Agents Chemother. . 2009. 53(2). 401-411. Find at Google Scholar.
Howe AY, Cheng H, Johann S, Mullen S, Chunduru SK, Young DC, Bard J, Chopra R, Krishnamurthy G, Mans. Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofur. Antimicrob Agents Chemother . 2008. 52(9) . 3327-3338. Find at Google Scholar.
Villano Stephen, Anita Howe, Donald Raible, Dawn Harper, John Speth, Geraldine Bichier. . Analysis of HCV NS5B genetic variants following monotherapy with HCV-796, a nonnucleoside polymerase. Hepatology . 2006. 44 (4) Suppl. 1. 607A-608A. Find at Google Scholar.
Shi ST, Herlihy KJ, Graham JP, Fuhrman SA, Doan C, Parge H, Hickey M, Gao J, Yu X, Chau F, Gonzalez . In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA. Antimicrob Agents Chemother . 2008. 52(2). 675-683. Find at Google Scholar.
Bartels DJ, Sullivan JC, Zhang EZ, Tigges AM, Dorrian JL, De Meyer S, Takemoto D, Dondero E, Kwong A. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely. J Virol. . 2013. 87(3). 1544-1553. Find at Google Scholar.
Paolucci S, Fiorina L, Mariani B, Gulminetti R, Novati S, Barbarini G, Bruno R, Baldanti F. . Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA. Virol J. . 2013. 10. 355. Find at Google Scholar.
Middleton T, He Y, Beyer J, Menon R, Klein C, Cohen D, Collins C. . Resistance profile of ABT-333 and relationship to viral load decrease in patients treated in combina. J. Hepatol. . 2010. 52. S296-S297. Find at Google Scholar.
Sun SC, Bae A, Qi X, Harris J, Wong KA, Miller MD, Mo H. . Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-naive HCV patient. J Viral Hepat. . 2011. 18(12) . 861-870. Find at Google Scholar.
Zeuzem S, Buggisch P, Agarwal K, Marcellin P, Sereni D, Klinker H, Moreno C, Zarski JP, Horsmans Y, . The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribav. Hepatology . 2012. 55(3) . 749-758. Find at Google Scholar.
Trevino A, de Mendoza C, Parra P, Rodriguez C, Madejan A, Plaza Z, del Romero J, Poveda E, Soriano V. Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HI. Antivir Ther. . 2011. 16(3). 413-416. Find at Google Scholar.